Thymosin Alpha-1 BPC-157 for Lyme Research | Real Peptides Researchers at Stanford's Lyme Disease Research Program documented a pattern in 2024 that shifted how the field thinks about chronic Lyme treatment: patients wi…
Read articleThymosin Alpha-1 Thymalin Protocol Thymus Research Research published in the International Journal of Immunopharmacology identified thymosin alpha-1 as a toll-like receptor 9 (TLR9) modulator capable of activating dendr…
Read articleThymosin Alpha-1 BPC-157 Protocol Lyme Research A 2022 pilot study from the Johns Hopkins Center for Lyme Disease Research examined immune markers in 42 patients with post-treatment Lyme disease syndrome (PTLDS). The pa…
Read articleStacking Thymosin Alpha-1 BPC-157 Lyme Research Findings Research published in the International Journal of Antimicrobial Agents found that Borrelia burgdorferi. The spirochete responsible for Lyme disease. Persists in …
Read articleStacking Thymosin Alpha-1 VIP Long COVID Research Research from Stanford's Long COVID initiative found that up to 68% of patients with persistent symptoms six months post-infection show measurable T-cell dysfunction. No…
Read articleThymosin Alpha-1 VIP Protocol Long COVID Research A 2025 observational cohort published in Frontiers in Immunology found that patients receiving combined thymosin alpha-1 and VIP therapy showed 42% improvement in fatigu…
Read articleThymosin Alpha-1 VIP Long COVID Research — Peptide Trials A 2024 Phase 2 trial at Yale School of Medicine found that thymosin alpha-1 (Tα1) reduced markers of T-cell exhaustion by 42% in long COVID patients after eight …
Read articleStacking Thymosin Alpha-1 Thymalin Thymus Research Protocols A 2023 study published in the Journal of Immunology Research found that combining thymosin alpha-1 (Tα1) with thymalin in aged mice restored thymic output to …
Read articleThymosin Alpha-1 & Thymalin for Thymus Research Research conducted at the Institute of Bioregulation and Gerontology in Saint Petersburg found that thymalin administration increased CD4+ T-cell counts by 47% in aged ani…
Read articleStacking Thymosin Alpha-1 LL-37 Immune Research A 2023 in vitro study published by researchers at the University of Naples found that co-administration of thymosin alpha-1 and LL-37 produced a 3.2-fold increase in neutr…
Read articleThymosin Alpha-1 LL-37 Protocol Immune Research Research from the University of Texas Medical Branch found that thymosin alpha-1 increased CD4+ and CD8+ T-cell counts by 40–60% in immunocompromised patients within 28 da…
Read articleCerebrolysin BPC-157 Protocol TBI Research — 2026 Studies A 2024 preclinical study published by researchers at the Department of Neuroscience, University of Belgrade, found that combining Cerebrolysin with BPC-157 in se…
Read articleStacking Cerebrolysin BPC-157 TBI Research — What Works The single biggest error in TBI peptide research isn't choosing the wrong compound. It's stacking them incorrectly. Cerebrolysin and BPC-157 operate through entire…
Read articleCerebrolysin BPC-157 for TBI Research — What Science Shows Animal models of traumatic brain injury treated with cerebrolysin show 30–40% reductions in lesion volume compared to controls. But that's only half the story. …
Read articleEpithalon Sermorelin Protocol Longevity + GH — Real Evidence Fewer than 15% of clinicians prescribing peptide longevity protocols understand the mechanistic difference between epithalon and sermorelin. And that gap show…
Read articleNAD+ MOTS-C for Metabolic Research — Peptide Mechanisms A 2023 study published in Cell Metabolism found that combining NAD+ supplementation with MOTS-C peptide administration produced mitochondrial ATP output improvemen…
Read articleNAD+ MOTS-C Protocol Metabolic Research | Real Peptides A 2022 study published in Cell Metabolism found that MOTS-c administration restored age-related insulin sensitivity loss in mice by 73% within eight weeks. A resul…
Read articleStacking NAD+ MOTS-C Metabolic Research — Real Peptides Research published in Cell Metabolism (2021) demonstrated that MOTS-C administration in aged mice restored insulin sensitivity to levels comparable to young contro…
Read articleNAD+ SS-31 Protocol — Mitochondrial Research Explained Research published in Cell Metabolism found that NAD+ depletion reduces mitochondrial respiratory capacity by up to 50% in aged tissues. But supplementation alone r…
Read article5-Amino-1MQ MOTS-C for Metabolic Stack — Research Guide A 2022 study published in Cell Metabolism found that MOTS-C administration in aged mice restored insulin sensitivity to levels comparable to young controls. And wh…
Read article